Carl Zeiss Meditec AG
AFX: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€74.00 | Flthnp | Rsqxlzs |
Carl Zeiss: Leadership Change Doesn’t Alter Our Favorable Long-Term Outlook
Narrow-moat Carl Zeiss reported on Sept. 30 that Karl Lamprecht, chief executive officer and president, decided not to extend his contract. Lamprecht, who joined the firm in 2005 and has since tackled various roles, started serving as CEO in April 2020 and led the firm through the tumultuous pandemic period. Under Lamprecht’s leadership, Zeiss navigated challenges such as lockdowns across geographies and delivered impressive double-digit compound annual growth for sales and earnings over the last four years.